-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NIDO-361 in Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NIDO-361 in Kennedy's Disease (Spinal and Bulbar Muscular Atrophy) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NIDO-361 in Kennedy's Disease (Spinal and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Zeluvalimab in Small-Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Zeluvalimab in Small-Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Zeluvalimab in Small-Cell Lung Cancer Drug Details: AMG-404 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NIDO-361 in Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.NIDO-361 in Kennedy’s Disease (Spinal and Bulbar Muscular Atrophy)Drug Details:NIDO-361 is under development for the treatment...
-
Product Insights
NewTauopathies – Drugs In Development, 2024
Empower your strategies with our Tauopathies – Drugs In Development, 2024 report and make more profitable business decisions. Tauopathies are a group of neurodegenerative disorders characterized by the aggregation of tau protein into neurofibrillary or gliofibrillary tangles in the human brain. Tau protein normally stabilizes microtubules, which are essential for intracellular transport and communication. However, when tau becomes hyperphosphorylated or misfolded, it dissociates from microtubules and forms insoluble aggregates that impair neuronal function and survival. Tauopathies can present with various clinical...
-
Product Insights
NewSpinal Muscular Atrophy (SMA) – Drugs In Development, 2024
Empower your strategies with our Spinal Muscular Atrophy (SMA) – Drugs In Development, 2024 report and make more profitable business decisions. Spinal muscular atrophy (SMA) is a genetic disease that attacks nerve cells, called motor neurons, in the spinal cord. These critically important cells are responsible for supplying electrical and chemical messages to muscle cells. Without the proper input from the motor neurons, muscle cells cannot function properly. The muscle cells will, therefore, become much smaller (atrophy) and will produce symptoms...
-
Product Insights
NewFrontotemporal Dementia (FTD) – Drugs In Development, 2024
Empower your strategies with our Frontotemporal Dementia (FTD) – Drugs In Development, 2024 report and make more profitable business decisions. Frontotemporal dementia (FTD) encompasses various brain disorders leading to progressive damage in the frontal and temporal lobes. It manifests in distinct ways: behavioral changes, language difficulties, or movement impairments. Symptoms range from altered social conduct, lack of empathy, and impulsivity to language struggles or motor coordination issues. FTD's exact cause remains unclear, but abnormal protein deposits in the brain are implicated....
-
Product Insights
Spinal Fusion Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Spinal Fusion Pipeline Market Report Overview Spinal Fusion procedures are mainly performed on the cervical and thoracolumbar regions. Spinal fusion is a surgical procedure that involves joining two vertebrae in the spine to form a single solid bone, with the involvement of certain devices, to relieve pain. Conventional and Minimally Invasive Surgery (MIS) methods are used to perform Spinal Fusion. Conventional methods include all open surgical methods that are used for performing spinal procedures. The Spinal Fusion pipeline market research...
-
Product Insights
Cerro De Los Nidos Field
Cerro De Los Nidos Field is a producing field located in Mendoza, Argentina. It is being operated by YPF SA. Empower your strategies with our Cerro De Los Nidos Field report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data...
-
Product Insights
Galoc Field
Galoc Field is a producing field located in West Philippine Sea, Philippines. It is being operated by Nido Production (Galoc) Pty Ltd. Empower your strategies with our Galoc Field report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability...